Duncan C. Gilbert - Department of Chemistry;State Uni ˝ ersity of New York;Department of Chemistry, State Uni ˝ ersity of New York

基本信息

浏览量：115

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 128 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Getting our ducks in a row: The need for data utility comparisons of healthcare systems data for clinical trials

Matthew R. Sydes,Macey L. Murray,Saiam Ahmed,Sophia Apostolidou,Judith M. Bliss, Claire Bloomfield,Rebecca Cannings-John,James Carpenter,Tim Clayton,Madeleine Clout, Rebecca Cosgriff,Amanda Farrin,

Contemporary Clinical Trialspp.107514-107514, (2024)

引用0浏览0WOS引用

Understanding the molecular biology of anal squamous cell carcinoma

Robert J. Samuel,Duncan C. Gilbert

INTERNATIONAL JOURNAL OF CANCERno. 3 (2024): 410-411

引用0浏览0WOS引用

A Repurposing Programme Evaluating Transdermal Oestradiol Patches for the Treatment of Prostate Cancer Within the PATCH and STAMPEDE Trials: Current Results and Adapting Trial Design

D. C. Gilbert, M. Nankivell, H. Rush, N. W. Clarke, S. Mangar, A. Al-hasso, S. Rosen, R. Kockelbergh,S. K. Sundaram, S. Dixit, M. Laniado, N. McPhail,

CLINICAL ONCOLOGYno. 1 (2024): e11-e19

引用0浏览0WOS引用

204 REFINE-Lung is a multicentre phase III study to determine the optimal frequency of pembrolizumab in advanced non-small cell lung cancer (NSCLC) utilising a novel multi-arm design

Ehsan Ghorani,Matteo Quartagno,Fiona Blackhall, Mary O'Brien,Christian Ottensmeier,Elena Pizzo,James Spicer,Duncan Gilbert, Alex Baker, Philip Badman,Charlotte Milner-Watts, Paolo D. d'Arienzo,

Lung Cancer (2024): 107765

引用0浏览0引用

T-cell receptor determinants of response to chemoradiation in locally-advanced HPV16-driven malignancies

Pablo Nenclares, Adrian Larkeryd, Floriana Manodoro, Jen Y. Lee,Susan Lalondrelle,Duncan C. Gilbert, Marco Punta, Ben O'Leary,Antonio Rullan,Anguraj Sadanandam,Benny Chain,Alan Melcher,

FRONTIERS IN ONCOLOGY (2024): 1296948-1296948

引用0浏览0WOS引用

Re: Bertrand Tombal, Sean Collins, Alicia K. Morgans, et al. Impact of Relugolix Versus Leuprolide on the Quality of Life of Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study. Eur Urol 2023;84:579–87

Hannah L. Rush,Duncan C. Gilbert,Ruth E. Langley

European Urology（2024）

引用0浏览0WOS引用

Will Immune Checkpoint Inhibitors Allow the Non-operative Management of Mismatch Repair-deficient Colorectal Cancer to Become a Standard of Care

H. Sinclair, T. Ranji,D.C. Gilbert

Clinical Oncologyno. 3 (2024): 136-140

引用0浏览0WOS引用

REFINE-Lung: A multicentre phase III study to determine the optimal frequency of pembrolizumab in non-small cell lung cancer utilising a novel multi-arm design

Michael Seckl,Ehsan Ghorani,Matteo Quartagno,Fiona Helen Blackhall,Duncan C. Gilbert,Mary E. R. O'Brien,Christian H. H. Ottensmeier,Elena Pizzo,James F. Spicer,Alex Williams, Philip David Badman,Mahesh K. B. Parmar

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): TPS9145-TPS9145

引用0浏览0引用

A comparison of different population-level summary measures for randomised trials with time-to-event outcomes, with a focus on non-inferiority trials

Matteo Quartagno,Tim P Morris,Duncan C Gilbert,Ruth E Langley,Matthew G Nankivell,Mahesh Kb Parmar,Ian R White

Clinical trials (London, England)（2023）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn